In a statement Japanese drug maker Shionogi & Co Ltd said, their experimental treatment for COVID-19 has shown rapid clearance of the virus that causes the disease. The pill, S-217622, “demonstrated rapid clearance of the infectious SARS-CoV-2 virus”, said Shionogi… Read More ›
According to two sources who have seen the lab results, China’s CoronaVac, its COVID-19 vaccine, developed by Sinovac Biotech, has a general efficacy of less than 60% in clinical trial in Brazil. Brazil’s Sao Paulo’s Butantan biomedical center, which has… Read More ›
On Thursday, in a statement Japan’s Fujifilm Holdings Corp said, it has signed a manufacturing contract with U.S.-based VLP Therapeutics for manufacturing a COVID-19 vaccine. In a statement both companies said, “Fujifilm will use its manufacturing facilities and infrastructure to… Read More ›
manageria.biz 